Investor profile
Irving Investors has backed 2 European tech companies across 2 funding rounds between 2021 and 2022, joining rounds totalling €264M. Most active in Healthtech and Cybersecurity. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Cybereason | Israel | 1 | €233M |
| DNA Script | France | 1 | €31M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Cybereason | Other | €233M | 2021-07 |
| DNA Script | Series C | €31M | 2022-01 |
